Mahsa Abrishami, DVM, MSc, PhD

---

Dr. Mahsa Abrishami is an accomplished clinical development leader with a distinctive dual DVM/PhD background that provides a unique perspective in drug development. She brings extensive expertise across the entire drug development continuum, from conceptualization through strategic early development, safety pharmacology, toxicology, and DMPK studies to Phase I/II clinical trials. 

Dr. Abrishami specializes in precision medicine and immuno-oncology, with deep scientific knowledge in novel bispecific antibodies and their clinical applications. Her expertise extends to neuroscience drug pipelines, where she has demonstrated proficiency in novel neuroscience and pain studies for drug formulation selection, pipeline development, safety pharmacology, and clinical trials.

Currently serving as a consultant for nonclinical and clinical studies, Dr. Abrishami has proven leadership experience in developing three drug pipelines from concept to Phase II within five years. She has successfully expanded clinical trials to new jurisdictions, achieving an 18% increase in operational efficiency while navigating complex regulatory challenges.

Dr. Abrishami is an active inventor with multiple patents in pain management, including:

• "Cannabichromene formulation for pain management" (Patent Number: CA2021/051602)
• Several provisional patents for innovative therapeutic approaches
• "Formulation for pain management" (Patent Number: CA2020/050588) where she led and designed supporting studies

Her innovative work has entered the patent highway with no prior art, demonstrating significant novelty in the therapeutic landscape.

As Global Lead of Clinical Research at ZYUS Life Sciences Inc., Dr. Abrishami spearheaded the "Think Harmonized Clinical" Initiative, resulting in significant improvements in drug pipeline efficiency and harmonization across departments. She has extensive experience in regulatory engagement, building positive relationships with authorities and ensuring compliance throughout the development process.

Dr. Abrishami has completed advanced leadership training through the 360-Degree Leadership Program with Executive One Leadership Coaching, enhancing her cross-functional leadership abilities and precision in navigating complex clinical operations.

• PhD in Health Sciences – Immuno-oncology, University of Saskatchewan (2012-2018) 
  • Dissertation: "Generation of synthetic antibodies as potential therapeutics to block IL3–mediated innate imatinib resistance in chronic myeloid leukemia"
• MSc in Biomedical Sciences, Western College of Veterinary Medicine, University of Saskatchewan (2005-2008)
• Doctor of Veterinary Medicine (DVM), Ferdowsi University of Mashhad, Iran (1998-2004)

Dr. Abrishami's research background includes significant work at the Saskatchewan Cancer Research Agency in translational cancer research, where she applied advanced molecular biology techniques including cloning, mutagenic DNA library generation, gene expression analysis, and development of bispecific and bivalent antibody fragments for therapeutic applications.

She has also served as a Health Sciences Liaison and Technology Analyst at the University of Saskatchewan's Innovation Enterprise, where she guided out-licensing decisions for medical technologies and conducted strategic market research for industry partner engagement.

• Strategic planning and logistics excellence in clinical trials
• Cross-functional team leadership and collaboration
• Regulatory strategy and compliance
• Patient-centric recruitment strategies and partnerships with advocacy groups
• Business impact through IP portfolio enhancement and operational efficiency
• Outstanding communication and presentation skills

Dr. Abrishami's deep commitment is to advance therapeutics, drive clinical development, and instigate positive strategic change in healthcare for patients in need.

At NexusBio Partners, we specialize in providing expert consulting services for drug development in the biotechnology sector. Our team of experienced professionals offers insights that can help streamline your research processes and enhance your product development timelines. We are committed to guiding you through the complexities of biotech with tailored strategies.